Related references
Note: Only part of the references are listed.Gastro-protective and Anti-stress Efficacies of Monomethyl Fumarate and a Fumaria indica Extract in Chronically Stressed Rats
Anshul Shakya et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
Erin E. Longbrake et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
Erin E. Longbrake et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages
Ranran Han et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
Heidi Vego et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi et al.
ACTA NEUROPATHOLOGICA (2015)
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity
Reiner Kunze et al.
EXPERIMENTAL NEUROLOGY (2015)
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway
Qin Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells
Axel Haarmann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Anti-CD40-induced inflammatory E-cadherin plus dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma
Yong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage
Loretta O. Iniaghe et al.
NEUROBIOLOGY OF DISEASE (2015)
Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
Zaidoon Al-Jaderi et al.
TOXINS (2015)
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Collin M. Spencer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Dimethyl fumarate protection against collagen II degradation
Ye Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE
Hui Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cyclin-Dependent Kinase 9 Inhibition Protects Cartilage From the Catabolic Effects of Proinflammatory Cytokines
Jasper H. N. Yik et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
Ralf A. Linker et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
Martin Stangel et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
R. Gold et al.
CLINICAL IMMUNOLOGY (2012)
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
De-Hyung Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad Signaling
Chang Joo Oh et al.
PLOS ONE (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1
Shao Xia Lin et al.
ASN NEURO (2011)
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Kamran Ghoreschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
Melissa Garcia-Caballero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated Colitis
Karima R. R. Siddiqui et al.
IMMUNITY (2010)
The role of drugs in the induction and/or exacerbation of psoriasis
Kabbur Hanumanthappa Basavaraj et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Fumarase: A Mitochondrial Metabolic Enzyme and a Cytosolic/Nuclear Component of the DNA Damage Response
Ohad Yogev et al.
PLOS BIOLOGY (2010)
The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis
Anne Lise K. Hestvik
TOXINS (2010)
Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis
D. Moharregh-Khiabani et al.
CURRENT NEUROPHARMACOLOGY (2009)
Molecular Mechanisms of Nrf2-Mediated Antioxidant Response
Wenge Li et al.
MOLECULAR CARCINOGENESIS (2009)
The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
Hua Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies
Ralf A Linker et al.
Expert Review of Neurotherapeutics (2008)
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression
Simone A. Rubant et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Ludwig Kappos et al.
LANCET (2008)
The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
D. A. Frohlich et al.
ONCOGENE (2008)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2
Changjiang Xu et al.
CANCER RESEARCH (2006)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Oral fumaric acid esters for the treatment of active multiple sclerosis:: an open-label, baseline-controlled pilot study
S. Schimrigk et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Effects of monomethylfumarate on dendritic cell differentiation
NHR Litjens et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Oxidative and electophilic stresses activate Nrf2 through inhibition of ubiquitination activity if Keap1
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters
KJ Zhu et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2005)
Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation
F Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells
A Wierinckx et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies
J Aronowski et al.
NEUROLOGICAL RESEARCH (2005)
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells
AA Maghazachi
PHARMACOLOGICAL REVIEWS (2005)
Dimethylfumarate for psoriasis: more than a dietary curiosity
U Mrowietz et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in downregulated Th1 lymphocyte responses
NHR Litjens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate for proteasomal degradation of Nrf2
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles
H Moed et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Immunopathogenic mechanisms in psoriasis
JE Gudjonsson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles
K Itoh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Pharmacokinetics of oral fumarates in healthy subjects
NHR Litjens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters
D Werdenberg et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2003)
Tumor necrosis factor-α induces early-onset endothelial adhesivity by protein kinase Cζ-dependent activation of intercellular adhesion molecule-1
K Javaid et al.
CIRCULATION RESEARCH (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Dimethylfumarate inhibits TNF-induced nuclear entry of NF-κB/p65 in human endothelial cells
R Loewe et al.
JOURNAL OF IMMUNOLOGY (2002)
Inhibition of dendritic cell differentiation by fumaric acid esters
KJ Zhu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Share Paper
